Ram I. Mahato

Affiliations: 
1999-2001 University of Utah, Salt Lake City, UT 
 2004-2013 University of Tennessee Health Science Center, Memphis, TN, United States 
 2013- University of Nebraska Medical Center, Omaha, NE, United States 
Area:
Pharmaceutical Chemistry
Google:
"Ram I. Mahato"
Bio:

https://en.wikipedia.org/wiki/Ram_I._Mahato
https://www.unmc.edu/pharmacy/faculty/CVs/MahatoCV.pdf

Mean distance: (not calculated yet)
 

Children

Sign in to add trainee
Ajit S. Narang grad student 2006 UTHSC
Zhaoyang Ye grad student 2007 UTHSC
Ravikiran Panakanti grad student 2010 UTHSC
Ningning Yang grad student 2011 UTHSC
Michael Danquah grad student 2012 UTHSC
Jitender Bariwal research scientist 2017- UNMC
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Bhattarai RS, Bariwal J, Kumar V, et al. (2022) pH-sensitive nanomedicine of novel tubulin polymerization inhibitor to lung metastatic melanoma. Journal of Controlled Release : Official Journal of the Controlled Release Society
Kumar V, Sethi B, Yanez E, et al. (2022) Effect of magnesium stearate surface coating method on the aerosol performance and permeability of micronized fluticasone propionate. International Journal of Pharmaceutics. 615: 121470
Bhattarai RS, Kumar V, Romanova S, et al. (2020) Nanoformulation design and therapeutic potential of a novel tubulin inhibitor in pancreatic cancer. Journal of Controlled Release : Official Journal of the Controlled Release Society
Kumar V, Bariwal J, Narang AS, et al. (2020) Functional similarity of modified cascade impactor to deposit drug particles on cells. International Journal of Pharmaceutics. 119404
Wang Q, Kumar V, Lin F, et al. (2020) ApoE mimetic peptide targeted nanoparticles carrying a BRD4 inhibitor for treating Medulloblastoma in mice. Journal of Controlled Release : Official Journal of the Controlled Release Society
Peng Y, Bariwal J, Kumar V, et al. (2020) Organic Nanocarriers for Delivery and Targeting of Therapeutic Agents for Cancer Treatment Advanced Therapeutics. 3: 1900136
Kumar V, Dong Y, Kumar V, et al. (2019) The use of micelles to deliver potential hedgehog pathway inhibitor for the treatment of liver fibrosis. Theranostics. 9: 7537-7555
Bariwal J, Kumar V, Chen H, et al. (2019) Nanoparticulate delivery of potent microtubule inhibitor for metastatic melanoma treatment. Journal of Controlled Release : Official Journal of the Controlled Release Society
Yang R, Chen H, Guo D, et al. (2019) Polymeric Micellar Delivery of Novel Microtubule Destabilizer and Hedgehog Signaling Inhibitor for Treating Chemoresistant Prostate Cancer. The Journal of Pharmacology and Experimental Therapeutics
Kumar V, Sethi B, Kumar V, et al. (2019) Abstract 15: Targeting vismodegib-resistant medulloblastoma using novel hedgehog pathway inhibitor and miR-29b mimic Cancer Research. 79: 15-15
See more...